Literature DB >> 7019049

Autoantibody responses to liver-specific lipoprotein in mice.

W N Bartholomaeus, W D Reed, R A Joske, K B Shilkin.   

Abstract

Autoantibody to the hepatocyte membrane antigen, liver-specific lipoprotein (LSP) was induced in mice by immunization with LSP-containing protein preparations from human, rat, rabbit and mouse liver and also with purified allogeneic LSP. Each of the strains of mice used (C57B1, BALB/c, C3H) showed the capacity to produce high titre autoantibody to LSP. Autoantibody to LSP demonstrated by passive haemagglutination was absorbed by normal mouse hepatocytes but not by kidney or spleen cells and reacted with the cell membrane of normal mouse hepatocytes by immunofluorescence. The liver was examined histologically in all mice and where inflammation was found it was attributable to the Freund's complete adjuvant used in immunization rather than liver protein immunogen. The demonstration of high titre autoantibody to LSP in mice without associated hepatitis contrasts with chronic hepatitis in man and experimental chronic hepatitis in rabbits where autoantibodies to LSP have been implicated in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019049      PMCID: PMC1555006     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.

Authors:  H Warnatz; F Scheiffarth; R Schmeissner
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

3.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

4.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

5.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

6.  Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte?

Authors:  A H Greenberg; L Shen; I M Roitt
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

7.  Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.

Authors:  A H Greenberg; L Shen; G Medley
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

8.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

9.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

10.  Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.

Authors:  H L Spiegelberg; H Perlmann; P Perlmann
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

View more
  7 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.

Authors:  I H Frazer; I J Kronborg; I R Mackay
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

3.  Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse.

Authors:  W N Bartholomaeus; H O'Donoghue; W D Reed
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

4.  Study of cellular immunity in experimental autoimmune hepatitis in mice.

Authors:  Y Mori; T Mori; H Yoshida; S Ueda; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction.

Authors:  K Araki; H Yamamoto; S Fujimoto
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

6.  Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.

Authors:  W N Bartholomaeus; G R Shellam; J E Allan; W D Reed; R A Joske
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

7.  Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells.

Authors:  W N Bartholomaeus; W D Reed; R A Joske
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.